In short. The substance classes used to restore facial volume, how each behaves over time, and how the choice among them is reasoned rather than sold. Classes only, no brands.

Key points

  • A material that can be dissolved is a material whose mistakes can be corrected.
  • That is worth a great deal in a region as unforgiving as the face, and it is a reasonable reason to choose a temporary material over a permanent one.

Facial volume loss is the change most often mistaken for sagging, and the one most often treated in the wrong layer. This article describes the classes of material used to restore volume and how the choice among them is reasoned. It deliberately names no products: brands change, classes do not.

Why volume, and where

Ageing deflates some compartments and enlarges others. The temple hollows, the periorbital region loses support, the midface flattens, and the chin and jawline lose projection, while the lower face may gain fat. Restoring volume is therefore a mapping exercise rather than a filling exercise: what is placed matters less than where, how much, and at what depth.

Autologous fat

The patient's own fat, harvested and reinjected, is the only material that becomes living tissue at the recipient site. Its advantages are biological integration and the absence of a foreign body. Its disadvantages are equally real. Harvest requires a donor site, a proportion of the transferred fat is resorbed unpredictably, the result cannot be dissolved, and large-volume transfer is a surgical procedure with surgical risks.

Hyaluronic acid fillers

These are gels rather than permanent implants, and their defining advantage is reversibility: a specific enzyme can dissolve them if a result is unsatisfactory or a complication occurs. They are used for contour, projection and moderate volume, and their behaviour depends on the formulation's viscosity, elasticity and water-binding, which determine the depth at which they belong. Risks include bruising, swelling, nodules, migration over time, and rarely but importantly vascular occlusion, which is a medical emergency and one of the strongest arguments for treatment in a hospital setting.

Reversibility is a clinical feature

A material that can be dissolved is a material whose mistakes can be corrected. That is worth a great deal in a region as unforgiving as the face, and it is a reasonable reason to choose a temporary material over a permanent one.

Biostimulatory materials

These are not volumizers in the conventional sense. They prompt the patient's own tissue to produce collagen, so the change develops gradually over months rather than appearing immediately, and it cannot be dissolved or removed. They suit patients seeking a gradual, natural-looking improvement and are less suited to those who want a defined immediate change or who need reversibility. Nodule formation, swelling and an unpredictable magnitude of response are recognized considerations.

Choosing between classes

The reasoning runs through the durability wanted, the reversibility required, the region and depth, previous treatments, history of scarring or inflammation, and the patient's tolerance for a surgical donor site. Combinations are common and legitimate, and so is declining all of them when the dominant change is descent rather than deflation.

Do not proceed if

  • A material is described as permanent, risk-free or unable to be dissolved, when no such material exists.
  • Volume is proposed in a region where the underlying change is descent or bone loss, with no explanation of what the added weight will do.
  • There is no plan for an unsatisfactory result, or treatment is offered where a vascular complication could not be managed.

A word on maintenance

Fat transferred is not necessarily fat retained, and fillers and biostimulatory materials are absorbed or metabolized over time. A volume plan is therefore a long-term plan with review points rather than a single correction.

Related reading

Frequently asked questions

Why does the choice of volume material matter less than where it is placed?

Because restoring volume is a mapping exercise rather than a filling exercise. Ageing deflates some compartments, such as the temple, periorbital region, and midface, while enlarging others in the lower face, so what matters is where, how much, and at what depth.

What is the advantage of a dissolvable material?

Its mistakes can be corrected. Hyaluronic acid gels can be dissolved with a specific enzyme if a result is unsatisfactory or a complication occurs, which is worth a great deal in a region as unforgiving as the face, and is a reasonable reason to prefer it.

How is the choice between material classes reasoned?

Through the durability wanted, the reversibility required, the region and depth, previous treatments, history of scarring or inflammation, and tolerance for a surgical donor site. Combinations are common and legitimate, and so is declining all of them when the dominant change is descent rather than deflation.

Risks & Limitations

  • Combining treatments multiplies recovery time and risk, and requires staging across visits.
  • Results vary with skin quality, anatomy, healing and adherence to aftercare.
  • Every modality carries its own risks — see the individual treatment guides for detail.
  • Maintenance is ongoing; no treatment stops the ageing process.
  • More is not better. Over-treatment is harder to correct than under-treatment.

When to Seek Care

  • Any red flag listed in the individual treatment guides — in particular severe pain, skin colour change, or vision change after injectables.
  • Difficulty breathing, chest pain or a swollen, painful calf — seek emergency care immediately.
  • Fever, spreading redness or a wound that is not healing.
  • Any reaction that is worsening rather than settling.

References & Further Reading

  • American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
  • American Academy of Dermatology (AAD) — skin health guidance
  • National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
  • World Health Organization (WHO) — healthy ageing resources

Medically reviewed by Tongchun Mao, MD (毛彤春), Deputy Director & Head of Aesthetic Surgery. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.